Table 5. Comparison of the two methods of ICG injection.
Intravenous injection via peripheral veins |
Indications: |
Gallbladder stone impaction |
Gallbladder filled with stones |
Gallbladder polyps |
Gallbladder atrophy |
Gallbladder polyps with potential malignancy |
Gallbladder adenomyomatosis |
Preoperative intravenous injection of ICG may not achieve optimal contrast enhancement in patients with: |
Liver cirrhosis |
Fatty liver |
Percutaneous injection via gallbladder |
Indications: |
Patients with liver cirrhosis |
Patients with fatty liver |
Gallbladder polyps without potential malignancy |
Single and freely movable gallbladder stone |
Gallbladder adenomyomatosis |
No risk of substances in the gallbladder dropping into the common bile duct after injection (e.g., gallbladder sandy stone) |
This injection method is not suitable if the patient has: |
Variant accessory hepatic ducts or aberrant hepatic ducts, as this method may not be suitable for fluorescence imaging |
Gallbladder stone impaction |
Gallbladder filled with stones |
Gallbladder polyps with potential malignancy |
Gallbladder atrophy |
ICG, indocyanine green.